GENERAL23 Sept 2026
Patient safety top priority for us: Pfizer after Karnataka FDA action
Karnataka's drug regulator has cancelled 16 licences and suspended eight more after counterfeit medicines were found being repacked and sold as branded drugs. Pfizer says it is helping the probe and has pulled affected batches from the market. If you buy medicines, check batch numbers and packaging, and buy only from licensed chemists. Report anything suspicious to the FDA.
Key Statutory Highlights
- The Karnataka Food and Drug Administration cancelled 16 drug licences of retailers and wholesalers and suspended eight others over the alleged distribution and sale of spurious medicines.
- The action followed an August 18 inspection where an alleged unlicensed repacking and relabelling operation was busted at a farmhouse in Bidadi, Bengaluru South district.
- Spurious drugs, machinery and printing materials worth around ₹5.05 crore were seized, and a criminal case has been registered under the Drugs and Cosmetics Act, 1940.
Actionable Advice for Taxpayers / Founders:If you deal in or buy medicines, keep purchase invoices and batch details handy and buy only from licensed sellers. If you suspect a spurious batch, you may report it to the Karnataka FDA, as Pfizer says it is cooperating with the authorities.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: